Juan R Rey
Overview
Explore the profile of Juan R Rey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Caro-Codon J, Rey J, Iniesta A, Rosillo S, Castrejon-Castrejon S, Rodriguez-Sotelo L, et al.
Rev Port Cardiol
. 2022 Jul;
41(10):823-830.
PMID: 35784098
Background: Chronic use of Angiotensin-converting enzyme (ACE) inhibitors (ACEi) and aldosterone-receptor blockers (ARB) is not associated with worse outcomes in patients with COVID-19. However, evidence on the impact of their...
3.
Rey J, Merino Llorens J, Iniesta Manjavacas A, Rosillo Rodriguez S, Castrejon-Castrejon S, Arbas-Redondo E, et al.
Med Clin (Engl Ed)
. 2022 Jun;
158(12):586-595.
PMID: 35693916
Aims And Objectives: Statins have been proposed as potentially useful agents for modulating the host response in COVID-19. However, solid evidence-based recommendations are still lacking. Our aim was to study...
4.
Severo Sanchez A, Rey J, Iniesta A, Merino J, Castrejon-Castrejon S, Lopez-de-Sa E, et al.
Rev Port Cardiol
. 2021 Nov;
41(4):355-357.
PMID: 34840414
No abstract available.
5.
Caro-Codon J, Rey J, Buno A, Iniesta A, Rosillo S, Castrejon-Castrejon S, et al.
Med Clin (Engl Ed)
. 2021 Sep;
157(6):274-280.
PMID: 34568576
Background: Myocardial injury has been identified as a common complication in patients with COVID-19. However, recent research has serious limitations, such as non-guideline definition of myocardial injury, heterogenicity of troponin...
6.
Rey J, Merino Llorens J, Iniesta Manjavacas A, Rosillo Rodriguez S, Castrejon-Castrejon S, Arbas-Redondo E, et al.
Med Clin (Barc)
. 2021 Sep;
158(12):586-595.
PMID: 34511251
Aims And Objectives: Statins have been proposed as potentially useful agents for modulating the host response in COVID-19. However, solid evidence-based recommendations are still lacking. Our aim was to study...
7.
Caro-Codon J, Rey J, Buno A, Iniesta A, Rosillo S, Castrejon-Castrejon S, et al.
Med Clin (Barc)
. 2021 Apr;
157(6):274-280.
PMID: 33846001
Background: Myocardial injury has been identified as a common complication in patients with COVID-19. However, recent research has serious limitations, such as non-guideline definition of myocardial injury, heterogenicity of troponin...
8.
Rey J, Caro-Codon J
Med Clin (Barc)
. 2021 Feb;
156(7):336-338.
PMID: 33640169
No abstract available.
9.
Caro-Codon J, Lip G, Rey J, Iniesta A, Rosillo S, Castrejon-Castrejon S, et al.
Europace
. 2021 Feb;
23(6):937-947.
PMID: 33564822
Aims: Age, sex, and cardiovascular disease have been linked to thromboembolic complications and poorer outcomes in COVID-19. We hypothesize that CHADS2 and CHA2DS2-VASc scores may predict thromboembolic events and mortality...
10.
Caro-Codon J, Rey J, Buno A, Iniesta A, Rosillo S, Castrejon-Castrejon S, et al.
Eur J Heart Fail
. 2021 Jan;
23(3):456-464.
PMID: 33421281
Aims: Extensive research regarding the association of troponin and prognosis in coronavirus disease 2019 (COVID-19) has been performed. However, data regarding natriuretic peptides are scarce. N-terminal pro B-type natriuretic peptide...